Altimmune Inc (GB:0A4C)

Altimmune (0A4C) Stock Price & Analysis


0A4C Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.92 - $23.17
Previous Close$4.1
Average Volume (3M)19.35K
Market Cap
Enterprise Value$40.24M
Total Cash (Recent Filing)$165.76M
Total Debt (Recent Filing)$4.40M
Price to Earnings (P/E)N/A
Aug 15, 2023
Dividend YieldN/A
Share Statistics
Shares Outstanding49,292,189
10 Day Avg. Volume3,147
30 Day Avg. Volume19,346
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)1.34
Price to Sales (P/S)33822.07
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-509.39
Enterprise Value/Gross Profit-591.79
Enterprise Value/Ebitda-0.45
Price Target Upside494.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5




What was Altimmune Inc’s price range in the past 12 months?
Altimmune Inc lowest stock price was $3.92 and its highest was $23.17 in the past 12 months.
    What is Altimmune Inc’s market cap?
    Currently, no data Available
    When is Altimmune Inc’s upcoming earnings report date?
    Altimmune Inc’s upcoming earnings report date is Aug 15, 2023 which is in 76 days.
      How were Altimmune Inc’s earnings last quarter?
      Altimmune Inc released its earnings results on May 11, 2023. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.48 by $0.08.
        Is Altimmune Inc overvalued?
        According to Wall Street analysts Altimmune Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Altimmune Inc pay dividends?
          Altimmune Inc pays a Notavailable dividend of $873 which represents an annual dividend yield of N/A. See more information on Altimmune Inc dividends here
            What is Altimmune Inc’s EPS estimate?
            Altimmune Inc’s EPS estimate is -$0.47.
              How many shares outstanding does Altimmune Inc have?
              Currently, no data Available
              What happened to Altimmune Inc’s price movement after its last earnings report?
              Altimmune Inc reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.48. Following the earnings report the stock price went up 8.94%.
                Which hedge fund is a major shareholder of Altimmune Inc?
                Among the largest hedge funds holding Altimmune Inc’s share is Ardsley Advisory Partners. It holds Altimmune Inc’s shares valued at 6M.


                  Altimmune Stock Smart Score

                  The Altimmune Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Altimmune Inc

                  The Group is development stage company which intend to acquire an operating business, through a merger, capital stock exchange, asset acquisition or other similar business combination. The Group does not have any activities.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Inovio Pharmaceuticals
                  Eagle Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis